232 related articles for article (PubMed ID: 10389289)
1. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
Kitaoka S; Shiota G; Kawasaki H
Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
[TBL] [Abstract][Full Text] [Related]
3. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels and histopathology in chronic hepatitis B and chronic hepatitis C.
Akcam FZ; Tigli A; Kaya O; Ciris M; Vural H
J Interferon Cytokine Res; 2012 Dec; 32(12):570-4. PubMed ID: 23067363
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
[TBL] [Abstract][Full Text] [Related]
6. Circulating intercellular adhesion molecule-1 in chronic liver disease and hepatocellular carcinoma.
Huang YS; Wu JC; Chan CY; Chao Y; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Aug; 62(8):487-95. PubMed ID: 10462824
[TBL] [Abstract][Full Text] [Related]
7. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
8. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?
Hammad LN; Abdelraouf SM; Hassanein FS; Mohamed WA; Schaalan MF
J Immunotoxicol; 2013; 10(4):380-6. PubMed ID: 23350952
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-32: a new proinflammatory cytokine involved in hepatitis C virus-related liver inflammation and fibrosis.
Moschen AR; Fritz T; Clouston AD; Rebhan I; Bauhofer O; Barrie HD; Powell EE; Kim SH; Dinarello CA; Bartenschlager R; Jonsson JR; Tilg H
Hepatology; 2011 Jun; 53(6):1819-29. PubMed ID: 21381070
[TBL] [Abstract][Full Text] [Related]
10. Change in inflammatory cytokine profiles after transarterial chemotherapy in patients with hepatocellular carcinoma.
Kim MJ; Jang JW; Oh BS; Kwon JH; Chung KW; Jung HS; Jekarl DW; Lee S
Cytokine; 2013 Nov; 64(2):516-22. PubMed ID: 24035756
[TBL] [Abstract][Full Text] [Related]
11. Association of inflammatory and anti-inflammatory cytokines with insulin resistance in chronic hepatitis C.
Hung CH; Lee CM; Chen CH; Hu TH; Jiang SR; Wang JH; Lu SN; Wang PW
Liver Int; 2009 Aug; 29(7):1086-93. PubMed ID: 19302182
[TBL] [Abstract][Full Text] [Related]
12. [Immune parameters in patients with chronic hepatitis C and with various histologic changes].
Sobchak DM; Monakova EA
Klin Med (Mosk); 2004; 82(4):49-52. PubMed ID: 15164510
[TBL] [Abstract][Full Text] [Related]
13. The relation between pathogenesis of liver cirrhosis, hepatic encephalopathy and serum cytokine levels: what is the role of tumor necrosis factor α?
Goral V; Atayan Y; Kaplan A
Hepatogastroenterology; 2011; 58(107-108):943-8. PubMed ID: 21830421
[TBL] [Abstract][Full Text] [Related]
14. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
[TBL] [Abstract][Full Text] [Related]
15. Correlations among the serum levels of some interleukins and the histopathological aspects in chronic viral hepatitis C.
Avrămescu CS; Comănescu V; Popescu SN; Turculeanu A; Bălăşoiu M; Popescu CF; Lungulescu M
Rom J Morphol Embryol; 2008; 49(1):57-62. PubMed ID: 18273504
[TBL] [Abstract][Full Text] [Related]
16. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
[TBL] [Abstract][Full Text] [Related]
17. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Zhang W; Yue B; Wang GQ; Lu SL
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
[TBL] [Abstract][Full Text] [Related]
19. Circulating IL-2, IL-10 and TNF-alpha in chronic hepatitis B: their relations to HBeAg status and the activity of liver disease.
Bozkaya H; Bozdayi M; Türkyilmaz R; Sarioglu M; Cetinkaya H; Cinar K; Köse K; Yurdaydin C; Uzunalimoglu O
Hepatogastroenterology; 2000; 47(36):1675-9. PubMed ID: 11149030
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
